Join Dr. Brian Lubbers and Dr. Brad White on this episode of After the Abstract where they discuss the paper titled: Clinical effectiveness of enrofloxacin 100 mg/mL injectable solution for the treatment of acute anaplasmosis in cattle caused by Anaplasma marginale.

Clinical effectiveness of enrofloxacin 100 mg/mL injectable solution for the treatment of acute anaplasmosis in cattle caused by Anaplasma marginale

After the Abstract is recorded with the goal of assisting veterinarians in the interpretation of scientific literature.  This podcast is not an endorsement of specific practices and medical decisions should only be made in consultation with your veterinarian. 

** Baytril CA-1 is no longer marketed for use in the US.